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The effect of tramadol and tramadol + gabapentin combination in patients with lumbar
disc herniation after epidural steroid injection
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Background/aim: To compare the effects of tramadol-only treatment and tramadol + gabapentin treatment in patients who had received
an epidural steroid injection.
Materials and methods: Forty patients with hernia disc-originated acute lumbar discogenic pain were evaluated. All patients received
a single dose of steroid and local anesthesia mixture epidurally via the lumbar approach. In both groups, Group T (tramadol, n =
20) and Group TG (tramadol + gabapentin, n = 20), the injection dose was adjusted to 4 mL of triamcinolone acetonide and 0.25%
bupivacaine mixture. Orally, 75 mg/day tramadol or 75 mg/day tramadol + 900 mg/day gabapentin were added to the treatment.
Leukocyte, erythrocyte sedimentation rate, C-reactive protein, and urine serotonin levels were measured prior to and after treatment.
The effectiveness of the treatment was evaluated by visual analog scale (VAS), Oswestry Disability Index (ODI), and straight leg elevation
test (SLET).
Results: Similar improvements in VAS, ODI, and SLET values were observed in both groups in the second week. The inflammation
markers were not different after treatment, neither within the groups nor between the groups.
Conclusion: This study revealed that tramadol + gabapentin treatment was not superior to tramadol treatment.
Key words: Lumbar disc herniation, epidural steroid injection, tramadol, gabapentin, lumbar radicular pain

1. Introduction
Lumbar radicular pain is an important problem,
particularly in developed and developing countries, and
causes serious physical, psychological, and economic losses
(1). One of the most frequent reasons for lumbar pain is
disc hernias. Mechanical pressure is not the only factor that
causes patient complaints. Local inflammatory processes
around the nerve root also contribute to the situation
(2,3). Epidural steroid injection (ESI) is an alternative and
effective method in reducing the inflammation of the nerve
root (4). Inflammatory mediators have been reported on
in few studies in the literature, while no information about
the relationship of the levels of these mediators in clinical
situations is present (5).
In herniated discs, nociceptive agents such as
prostaglandin E, serotonin, and histamine, which are
secreted from the area of the damaged disc, cause
inflammation and nerve root irritation. Corticosteroids
exhibit a stronger antiinflammatory effect and inhibit
* Correspondence: drhulyacicek@hotmail.com
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phospholipase A2, which catalyzes arachidonic acid
and a prostaglandin formation step from the membrane
phospholipids (6). Because of local inflammation,
inflammatory mediators such as interleukin 6 are produced
by monocytes and macrophages from the inflammation
region. These mediators may cause systemic inflammatory
reactions in high concentrations. Thus, C-reactive
protein (CRP) is thought to increase during lumbar
pain. Laboratory measurements of acute phase proteins
are important indicators for the degree of inflammation
and response to treatment. CRP is a sensitive marker
of inflammation and tissue damage, but erythrocyte
sedimentation rate (ESR) is not a specific marker (7).
In many experimental studies, serotonin was
demonstrated to have a role in neuropathic pain, and
5-hydroxytryptamine 2A (5-HT2A) receptors are reported
to have a role in spinal and peripheral sensitivity that
promotes analgesia by inhibiting neurotransmission of
nociceptive signals (8). Therefore, significant clinical
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effect is observed by using selective serotonin reuptake
inhibitors in dissipating many pain symptoms (9).
Tramadol, belonging to the weak opioid group according
to analgesic classification, is in fact a synthetic drug with
both opioid and nonopioid effect mechanisms. In addition
to its weak µ-opioid receptor agonist effect, it inhibits
presynaptic reuptake of noradrenaline (NA) and serotonin
(5-HT) and, at the same time, stimulates the secretion of
5-HT (10,11). Gabapentin is known as an anticonvulsant,
shown to have antihyperalgesic and antiallodynic effects in
animal and human studies (12,13).
In addition to ESI, treatment can be supported with
nonsteroidal antiinflammatory drugs (NSAIDs), muscle
relaxants, or antidepressants in patients with discogenic
lumbar pain. It has been reported that the treatment
success rate and the quality of life increase with ESI and
amitriptyline treatment (14).
This study aimed to compare the effects of an oral
tramadol-only treatment with a tramadol + gabapentin
combination on analgesia, clinical course, serotonin level,
and inflammatory response in patients who had received
an ESI.
2. Materials and methods
The study was undertaken at the hospital of the Gaziantep
University Medical Faculty, following approval by the
local ethics commission. This prospective, single-blind
study included 40 patients between the ages of 20 and
55 with herniated disc-derived acute lumbar radicular
pain present for no more than 3 months and a quality of
life score over 20% according to the Oswestry Disability
Index (ODI; 1–100; <20%: minimal disability, >35%:
serious disability), no surgical history, and radiologically
confirmed structural pathology without any neurological
deficits.
The patients were evaluated for 3 months. The exclusion
criteria were the discovery of bilateral or unilateral multiple
root pressure; neurological deficits; history of previous
lumbar vertebral surgery; serious cardiac, pulmonary,
hematological, gastrointestinal, liver, or kidney disease;
glaucoma; urinary retention; statin group drug usage;
hormone replacement therapy; and known allergy to
drugs used in the study.
Detailed locomotor system examinations; anteriorposterior, lateral, and oblique lumbosacral vertebra
radiographies; lumbar MRI investigations; and routine
hematological and biochemical tests that had been
performed on the patients in the previous 3 month period
were evaluated before the process. The initial interventions
and probable complications were briefly explained, and
written informed consent was obtained.
Patients who provided informed consent were
randomized into 2 groups as Group T (tramadol, n =

20) and Group TG (tramadol + gabapentin, n = 20). The
randomization was provided by an independent computer
consultant. Both groups were administrated a single
dose of steroid and local anesthetic mixture epidurally
by the lumbar approach. Before the procedure, blood
vessel cannulation was performed and the patients were
monitored (ECG, arterial blood pressure measurements,
pulse oximetry). In the prone position, subsequent to local
cleaning, the hernia level was determined by fluoroscopy.
The fluoroscopy-assisted lumbar transforaminal injection
was made in the epidural space using a 22-G spinal
needle. The injection dose was adjusted to 4 mL from
a triamcinolone acetonide (80 mg, Kenacort ampule,
Bristol-Myers Squibb) and 0.25% bupivacaine (10 mg)
mixture. Triamcinolone was preferred to betamethasone
because of its fast analgesic activity and its effectiveness
for ESIs due to its short-term advantages (15). Once it was
confirmed that the needle was not in the subarachnoid
space, 4 mL of the prepared mixture was injected. After
15 min, a superficial sense examination was performed
by the pin-prick method and the epidural analgesia was
monitored.
We used an oral form of short-acting tramadol (75
mg) once a day and 900 mg of gabapentin divided into 3
doses in 1 day. This 75 mg/day tramadol and the 75 mg/
day tramadol + 900 mg/day gabapentin combination
were initiated with oral administration to Group T and
Group TG, respectively. We started treatment with a
minimal effective dose but planned to increase the doses
2-fold if patients were suffering from pain higher than a
visual analog scale (VAS) score of 3, but VAS scores were
not higher than 3 during follow-up. We therefore did
not decrease the tramadol dose due to the addition of
gabapentin because we were using the lower doses.
Venous blood was collected by venipuncture into
sterile, siliconized Vacutainer tubes for leukocyte (WBC),
ESR, and CRP measurements, and spot urine samples
were obtained to detect serotonin levels before treatment
and 2 weeks after treatment.
WBC levels were determined with a complete blood
count, using the Roche Sysmex XT-2000 I hematology
analyzer (Roche, Mannheim, Germany). ESR was
determined by the Westergren method. Serum highsensitivity CRP levels were nephelometrically determined
with a Behring Nephelometer 100 Analyzer (Dade
Behring, Marburg, Germany).
An isocratic high-performance liquid chromatographic
(HPLC) system with an electrochemical detector was
used for the HPLC analysis of serotonin in the urine.
Accessories for electrochemical detectors were obtained
from Chromsystems (urine serotonin normal range: 28.4–
125 µmol/day, intraassay: CV < 2%, interassay: CV < 3%,
linearity: up to 1000 µg/L, limit of quantification: 5 µg/L,
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run time: approximately 8 min, injection volume: 20 µL,
potential: approximately 400 to 500 mV, internal standard:
solution of N-methyl serotonin).
In both groups, the analgesia level was evaluated by
VAS (0: no pain, 10: maximum pain), while daily activities
(walking, sleeping, social activities) were evaluated by ODI
(1–100; <20%: minimal disability, >35%: severe disability)
to determine quality of life, and objective determination
was evaluated by the straight leg raising test (SLET) (0°:
worst, 85°: best) before treatment and 2 weeks after the
procedure.
Evaluations of data were expressed for the 2 different
periods: the baseline sample, and 2 weeks after the
beginning of treatment (second week).
Power analysis was performed to determine the
proposed sample size in the design stage of the study. The
statistical analyses of the data were performed using the
Mann–Whitney U test for comparisons between groups
and the Wilcoxon test for the intragroup comparisons using
SPSS 11.0 for Windows. The intragroup comparisons were
performed according to the data at the beginning of the
study; the comparisons between groups were performed
based on the difference in percentages of the data at the
beginning and after the procedure.

3. Results
In total, 40 patients with hernia disc-originated acute
lumbar discogenic pain (27 females, 13 males) were
enrolled in the study and included in this analysis. The mean
age of patients was 45.82 ± 12.20 years (mean ± SD).The
patients were separated into 2 groups, Group T (tramadol,
n = 20) and Group GT (tramadol + gabapentin, n = 20).
The demographic and epidemiologic characteristics of the
patients in both groups were similar (Table 1). Vertebral
levels of disc herniation were between L5 and S1, duration
of pain was 0–12 weeks, and the mean values of VAS, ODI,
and SLET scores for each group were similar.
Evaluations concerning patient responses to treatments
are shown in Table 2. In the second week, VAS, ODI, and
SLET values were evaluated, and no statistically significant
difference was found between the groups (P > 0.05).
Second-week VAS and ODI values decreased and SLET
values increased significantly in both groups according to
the intragroup comparison (P < 0.05).
The ESR, CRP, and serotonin values of the patients did
not show any intergroup differences before treatment and
2 weeks after the treatment (Table 3). In the intragroup
evaluation, a significant increase was found in WBC values
of both groups after treatment (Group T: 7.44 ± 2.08 × 103/

Table 1. Demographic and preoperative epidemiologic data of the patients.
Group T (n = 20)

Group TG (n = 20)

Age (years)

47.70 ± 10.54

43.95 ± 13.86

Sex (female/male)

14/6

13/7

L3–L4

4 (20%)

4 (20%)

L4–L5

11 (55%)

12 (60%)

L5–S1

5 (25%)

4 (20%)

<2 weeks

8

10

2–6 weeks

7

7

7–12 weeks

5

3

VAS

7.05 ± 1.70

7.10 ± 1.20

ODI

38.00 ± 9.78

35.25 ± 9.10

SLET (0°–85°)

43.25 (20–60)

44.50 (20–50)

Vertebral level of disc herniation, N (%)

Duration of acute pain, N, mean

VAS = Visual analog scale, SLET = straight leg elevation test, ODI = Oswestry Disability Index.
Group T: 75 mg/day tramadol group (orally).
Group TG: 75 mg/day tramadol + 900 mg/day gabapentin group (orally).
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Table 2. Changes in visual analog scale, straight leg elevation test, and Oswestry
Disability Index during follow-up.

VAS
SLET
ODI

Baseline

Second week

Group T

7.05 ± 1.70

1.95 ± 1.27*

Group TG

7.10 ± 1.20

1.15 ± 1.08*

Group T

43.25 (30–60)

63.50 (30–75)*

Group TG

44.50 (35–60)

60.25 (50–70)*

Group T

38.00 ± 9.78

26.75 ± 9.63*

Group TG

35.25 ± 9.10

25.00 ± 8.11*

VAS = Visual analog scale, SLET = straight leg elevation test, ODI = Oswestry Disability
Index.
Group T: 75 mg/day tramadol group (orally).
Group TG: 75 mg/day tramadol + 900 mg/day gabapentin group (orally).
*P < 0.05 (significant differences within group).

Table 3. ESR, WBC, CRP, and serotonin levels of groups.

ESR (mm/h)
WBC (× 103/µL)
CRP (mg/L)
Serotonin (µg/L)

Baseline

Second week

Group T

18.20 ± 10.99

16.85 ± 10.99

Group TG

20.75 ± 16.34

17.75 ± 9.39

Group T

7.44 ± 2.08

10.28 ± 2.49*

Group TG

8.82 ± 1.95

11.29 ± 2.46*

Group T

7.68 ± 11.86

4.01 ± 1.95

Group TG

8.91 ± 12.64

5.32 ± 5.63

Group T

200.78 + 146.50

148.47 + 87.66

Group TG

178.98 + 144.96

204.68 + 125.74

ESR = Erythrocyte sedimentation rate, WBC = leukocyte count, CRP = C reactive
protein.
Group T: 75 mg/day tramadol group (orally).
Group TG: 75 mg/day tramadol + 900 mg/day gabapentin group (orally).
*P < 0.05 (significant differences within group).

µL vs. 10.28 ± 2.49 × 103/µL; Group TG: 8.82 ± 1.95 ×
103/µL vs. 11.29 ±2.46 × 103/µL), while no difference was
found in ESR, CRP, and serotonin values (P < 0.05).
4. Discussion
In this study, the use of tramadol-only and a tramadol
+ gabapentin combination in defined doses resulted in
similar clinical improvement, inflammatory response,
and serotonin levels in patients that received an ESI.
Furthermore, the WBC count increased in the second
week.

Data showed that a low dose of a combination of
tramadol and gabapentin shows a synergic effect in
preventing pain caused by formalin and may provide
a therapeutic advantage in the clinical treatment of
inflammatory pain (16). In the nonsurgical management
of pain in patients with unilateral cervical or lumbosacral
radiculopathy, a mixture of local anesthetic, tramadol,
and methylprednisolone was administrated via ESI and
accepted as an alternative technique for pain relief (17).
No study was found that investigated tramadol +
gabapentin treatment in addition to ESI. Tramadol and its
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metabolite, O-desmethyltramadol, showed antinociceptive
and antihyperalgesic effects via 5-HT7 receptors by the
activation of the serotonergic pathway (18).
Bloms-Funke et al. reported that tramadol increased
intracellular 5-HT and NA in the ventral hippocampi of
freely moving rats according to in vivo measurements (19).
A majority of the serotonergic fibers that play an
important role in pain modulation are placed anatomically
in the dorsal raphe of the brain. Furthermore, it is clear
that serotonin is secreted from the posterior horn by the
following conditions: stimulation of the sciatic nerve,
carrageenan-induced inflammatory pain, and chronic
pain (20).
The use of 5-HT2A inhibitors has relieved symptoms
in patients with a herniated lumbar disc (21). Kato et
al. reported that exogenous 5-HT secretion increases
during intervention of the nucleus pulposus of rats (22).
Ayres et al. demonstrated the genetic polymorphism of
catecholamine carriers, which play a crucial role within
the nervous system in terms of the reuptake of dopamine
and serotonin, in cases of acute clinical pain (23).
Generally, CRP levels are higher in patients with acute
lumbar sciatic pain. However, only one study could be
found concerning patients with chronic lumbar pain and
radicular pain. In another study, CRP and ESR levels were
expected to increase dependent on increased inflammatory
reactions, but they did not increase (7).
Ackerman et al. performed 3 sessions of lumbar ESI
(LESI) at 2-week intervals on patients with herniated discs
with various pathological intervertebral disc alterations
and used systemic inflammatory serum markers (complete
blood count, CRP, ESR) in determining the efficiency of
LESI. Complete blood count and ESR values were found

to be in the normal ranges and CRP was higher before the
LESI treatment (5).
Deniz et al. reported increased leukocyte levels in
patients with herniated discs, accompanied by sensory loss
as an examinational finding. They also reported a statistically
significant increase in ESR compared with the control
group in patients with herniated discs, accompanied by
reflex impairment as an examinational finding. However,
they also found that acute phase reactants were related to
examinational findings rather than to radiological findings
(24). Crawford et al. demonstrated no increase in ESR and
leukocyte levels of a patient with an acute herniated disc
imaged with MRI (25).
Anderson et al., in their studies of cattle, reported
leukocytosis (neutrophilia, eosinopenia, lymphopenia,
monocytosis), an increase in the neutrophil/lymphocyte
ratio, an increase in the CD4 lymphocyte percentage, and
a decrease in the total CD8 lymphocyte count depending
on dexamethasone usage (26). There are studies that
suggest a possible systemic effect of steroids used in ESI. In
these studies investigating the systemic effects of epidural
and intraarticular glucocorticoid injections, a significant
increase was reported in the glucose levels of diabetic and
nondiabetic patients (27–29). In our study, a clinically
insignificant increase in WBC values was found after
both groups received ESI. This increase may be explained
through the systemic effects of steroids.
In conclusion, in our study, we observed similar effects
of a tramadol + gabapentin combination and tramadolonly usage in defined doses on the clinical improvement,
inflammatory response, and serotonin levels in patients
with herniated lumbar discs who received an ESI.

References
1.

Bonica-Loeser JD. Low back pain. In: Loeser JD, editor. Bonica’s
Management of Pain. Philadelphia, PA, USA: Lippincott
Williams & Wilkins; 2001. pp. 1508–1564.

6.

Devor M, Govrin-Lippman R, Raber P. Corticosteroids
suppress ectopic neural discharge originating in experimental
neuromas. Pain 1985; 22: 127–137.

2.

Piperno M, Hellio le Graverand MP, Reboul P, Mathieu P,
Tron AM, Perrin G, Peschard MJ, Richard M, Vignon E.
Phospholipase A2 activity in herniated lumbar discs. Spine
1997; 22: 2061–2065.

7.

Park CH, Lee SH. Investigation of high-sensitivity C-reactive
protein and erythrocyte sedimentation rate in low back pain
patients. Korean J Pain 2010; 23: 147–150.

3.

Sugimori K, Kawaguchi Y, Morita M, Kitajima I, Kimura T.
High-sensitivity analysis of serum C-reactive protein in young
patients with lumbar disc herniation. J Bone Joint Surg Br
2003; 85: 1151–1154.

8.

4.

Rosen CD, Kahanovitz N, Bernstein R, Viola K. A retrospective
analysis of the efficacy of epidural steroid injection. Clin
Orthop Relat Res 1988; 228: 270–272.

Van Steenwinckel J, Brisorgueil MJ, Fischer J, Vergé D, Gingrich
JA, Bourgoin S, Hamon M, Bernard R, Conrath M. Role of
spinal serotonin 5-HT2A receptor in 2’,3’-dideoxycytidine
induced neuropathic pain in the rat and the mouse. Pain 2008;
137: 66–80.

9.

5.

Ackerman WE 3rd, Zhang JM. Serum hs-CRP as a useful
marker for predicting the efficacy of lumbar epidural
steroid injections on pain relief in patients with lumbar disc
herniations. J Ky Med Assoc 2006; 104: 295–299.

Bonaccorso S, Lin AH, Verkerk R, Van Hunsel F, Libbrecht I,
Scharpé S, DeClerck L, Biondi M, Janca A, Maes M. Immune
markers in fibromyalgia: comparison with major depressed
patients and normal volunteers. J Affect Disord 1998; 48: 75–
82.

1218

PİRBUDAK et al. / Turk J Med Sci
10.

Raffa RB, Friderichs E. Profile of tramadol and tramadol analog.
In: Bountra C, Munglani R, Schmidt K, editors. Pain: Current
Understanding, Emerging Therapies, and Novel Approaches to
Drug Discovery. New York, NY, USA: Marcel Dekker, 2003. pp.
731–742.

20.

Palazzo E, de Novellis V, Petrosino S, Marabese I, Vita D,
Giordano C, Di Marzo V, Mangoni GS, Rossi F, Maione S.
Neuropathic pain and the endocannabinoid system in the
dorsal raphe: pharmacological treatment and interactions with
the serotonergic system. Eur J Neurosci 2006; 24: 2011–2020.

11.

Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE,
Vaught JL. Opioid and nonopioid components independently
contribute to the mechanism of action of tramadol, an ‘atypical’
opioid analgesic. J Pharmacol Exp Ther 1992; 260: 275–285.

21.

Kanayama M, Hashimato T, Shigendou K, Togawa D, Oha
F. New treatment of lumbar disc herniation involving 5hydroxytryptamine2A receptor inhibitor: a randomized
controlled trial. J. Neurosurg Spine 2005; 2: 441–446.

12.

Dirks J, Petersen KL, Rowbotham MC, Dahl JB. Gabapentin
suppresses cutaneous hyperalgesia following heat-capsaicin
sensitization. Anesthesiology 2002; 97: 102–107.

22.

13.

Taylor CP, Gee NS, Su TZ, Kocsis JD, Welty DF, Brown JP,
Dooley DJ, Boden P, Singh L. A summary of mechanistic
hypotheses of gabapentin pharmacology. Epilepsy Res 1998;
29: 233–249.

Kato K, Kikuchi S, Konno S, Sekiguchi M. Participation of
5-hydroxytryptamine in pain related behavior induced by
nucleus pulposus applied on the nerve root in rats. Spine 2008;
33: 1330–1336.

23.

Ayres K, Kim H, Dionne R. The effects of genetic variation in
serotonin and dopamine transporters on acute clinical pain in
humans. J Pain 2006; 7: S4.

14.

Pirbudak L, Karakurum G, Oner U, Gulec A, Karadasli
H. Epidural corticosteroid injection and amitriptyline for
the treatment of chronic low back pain associated with
radiculopathy. Pain Clinic 2003; 15: 247–253.

24.

Deniz FE, Yıldırım B, Etikan İ. Relationship between acute
phase reactants and disc herniation. Türk Tıp Dergisi 2007; 1:
61–65 (in Turkish with English abstract).

15.

Pirbudak Cocelli L, Karakurum G, Cebesoy O, Karadaşlı
H, Oner U. Clinical comparison of effectiveness of epidural
triamcinolone and betamethasone in discal radiculalgia: a
prospective, randomized study. J Musculoskeletal Pain 2009;
17: 281–286.

25.

Crawford BA, Van der Wall H. Bone Scintigraphy in acute
intraosseous disc herniation. Clin Nucl Med 2007; 32: 790–
792.

26.

Anderson AE, Sayers BL, Haniffa MA, Swan DJ, Diboll J, Wang
XN, Isaacs JD, Hilkens CM. Differential regulation of naive
and memory CD4 + T cells by alternatively activated dendritic
cells. J Leukoc Biol 2008; 84: 124–133.

27.

Even JL, Crosby CG, Song Y, McGirt MJ, Devin CJ. Effects of
epidural steroid injections on blood glucose levels in patients
with diabetes mellitus. Spine 2012; 37: 46–50.

16.

Granados-Soto V, Argüelles CF. Synergic antinociceptive
interaction between tramadol and gabapentin after local,
spinal and systemic administration. Pharmacology 2005; 74:
200–208.

17.

Nawani DP, Agrawal S, Asthana V. Single shot epidural
injection for cervical and lumbosaccral radiculopathies: a
preliminary study. Korean J Pain 2010; 23: 254–257.

28.

18.

Yanarates O, Dogrul A, Yildirim V, Sahin A, Sizlan A, Seyrek
M, Akgül O, Kozak O, Kurt E, Aypar U. Spinal 5-HT7
receptors play an important role in the antinociceptive and
antihyperalgesic effects of tramadol and its metabolite,
O-Desmethyltramadol, via activation of descending
serotonergic pathways. Anesthesiology 2010; 112: 696–710.

Gonzalez P, Laker SR, Sullivan W, Harwood JE, Akuthota V.
The effects of epidural betamethasone on blood glucose in
patients with diabetes mellitus. PM R 2009; 1: 340–345.

29.

Younes M, Neffati F, Touzi M, Hassen-Zrour S, Fendri Y,
Béjia I, Ben Amor A, Bergaoui N, Najjar MF. Systemic effects
of epidural and intra-articular glucocorticoid injections in
diabetic and non-diabetic patients. Joint Bone Spine 2007; 74:
472–476.

19.

Bloms-Funke P, Dremencov E, Cremers TI, Tzschentke TM.
Tramadol increases extracellular levels of serotonin and
noradrenaline as measured by in vivo microdialysis in the
ventral hippocampus of freely-moving rats. Neurosci Lett
2011; 490: 191–195.

1219

